ceftobiprole medocaril sodium 667 MG Injection [Zevtera]

Verify with CMS →

ceftobiprole medocaril sodium

RxCUI: 2703567

Important: Drug coverage and costs vary by plan and location. Verify coverage directly with your Medicare plan before filling a prescription. This is informational data only and should not replace advice from your healthcare provider or pharmacist.
0.3%
Plan Coverage
16
Plans Covering
T4
Avg Tier
33.3%
Prior Auth Required

What the CMS Formulary Data Shows for ceftobiprole medocaril sodium 667 MG Injection [Zevtera]

Per the CMS 2026 Part D formulary file, ceftobiprole medocaril sodium 667 MG Injection [Zevtera] (RxNorm concept RXCUI 2703567, generic name ceftobiprole medocaril sodium) appears on 3 distinct formulary files spanning 16 Medicare Part D plan offerings - 0.3% of enrollable Part D products, selective placement; verify formulary inclusion before enrolling. Tier placement ranges from Tier 2 to Tier 5, with a cross-plan average of Tier 4.

Real-world access to ceftobiprole medocaril sodium 667 MG Injection [Zevtera] depends on utilization management as much as tier placement: 33.3% of covering formularies require prior authorization. 0% require step therapy. 0% apply quantity limits.

Medicare Part D spending dashboard figures are not published for this drug. The plan-by-plan detail below lists exactly which PDP and MA-PD contracts carry ceftobiprole medocaril sodium 667 MG Injection [Zevtera] today.

Coverage Details

Formularies covering
3
Plans covering
16
Coverage rate
0.3%
Tier range
Tier 2 – Tier 5
Average tier
Tier 4, Non-Preferred

Restrictions

Prior authorization required
33.3% of formularies
Step therapy required
0% of formularies
Quantity limits
0% of formularies

Tier Distribution Across Plans

1 plans
Tier 2, Generic
15 plans
Tier 5, Specialty

Medicare Advantage Plans (MA-PD) Covering ceftobiprole medocaril sodium 667 MG Injection [Zevtera]

16 Medicare Advantage plans with Part D drug coverage include this drug.

Plan Insurer Tier PA Premium States
CalOptima Health OneCare Complete (HMO D-SNP) ORANGE COUNTY HEALTH AUTHORITY T2 Yes $0 CA
UPMC for Life HMO Premier Rx (HMO) UPMC HEALTH PLAN, INC. T5 No $0 PA
UPMC for Life Complete Care (HMO D-SNP) UPMC FOR YOU, INC T5 No $0 PA
UPMC for Life Complete Care (HMO D-SNP) UPMC FOR YOU, INC T5 No $0 PA
UPMC for Life PPO Premier Rx (PPO) UPMC HEALTH NETWORK, INC. T5 No $0 PA
UPMC for Life PPO Premier Rx (PPO) UPMC HEALTH NETWORK, INC. T5 No $0 PA
UPMC for Life PPO Essential Care Rx (PPO) UPMC HEALTH NETWORK, INC. T5 No $0 PA
UPMC for Life Complete Care (HMO D-SNP) UPMC HEALTH COVERAGE, INC. T5 No $0 PA
UPMC for Life HMO Rx Choice (HMO) UPMC HEALTH PLAN, INC. T5 No $3.90 OH, PA
UPMC for Life HMO Deductible Rx (HMO) UPMC HEALTH PLAN, INC. T5 No $18.10 OH, PA
UPMC for Life PPO Rx Choice (PPO) UPMC HEALTH NETWORK, INC. T5 No $25.00 PA
UPMC for Life PPO High Deductible Rx (PPO) UPMC HEALTH NETWORK, INC. T5 No $33.00 PA
UPMC for Life HMO Rx (HMO) UPMC HEALTH PLAN, INC. T5 No $33.70 OH, PA
UPMC for Life PPO Rx Enhanced (PPO) UPMC HEALTH NETWORK, INC. T5 No $42.70 PA
UPMC for Life HMO Rx Enhanced (HMO) UPMC HEALTH PLAN, INC. T5 No $93.40 OH, PA
UPMC for Life PPO Rx Enhanced (PPO) UPMC HEALTH NETWORK, INC. T5 No $140.00 PA

Frequently Asked Questions

Is ceftobiprole medocaril sodium 667 MG Injection [Zevtera] covered by Medicare Part D?

Yes, ceftobiprole medocaril sodium 667 MG Injection [Zevtera] is covered by 16 Medicare Part D plans (0.3% of all Part D formularies).

What tier is ceftobiprole medocaril sodium 667 MG Injection [Zevtera] on Medicare Part D plans?

ceftobiprole medocaril sodium 667 MG Injection [Zevtera] averages Tier 4 across Part D plans, ranging from Tier 2 to Tier 5.

Does ceftobiprole medocaril sodium 667 MG Injection [Zevtera] require prior authorization?

33.3% of Part D formularies require prior authorization for ceftobiprole medocaril sodium 667 MG Injection [Zevtera]. Step therapy: 0%. Quantity limits: 0%.

Data sourced from the Centers for Medicare & Medicaid Services (CMS). See our methodology for details. Retrieved and formatted by PlainMedicare Editorial